SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-17-017360
Filing Date
2017-03-29
Accepted
2017-03-29 17:31:25
Documents
61
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K v462305_10k.htm 10-K 866573
2 EXHIBIT 23.1 v462305_ex23-1.htm EX-23.1 2310
3 EXHIBIT 31.1 v462305_ex31-1.htm EX-31.1 9656
4 EXHIBIT 32.1 v462305_ex32-1.htm EX-32.1 4746
  Complete submission text file 0001144204-17-017360.txt   5955865

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT rgrx-20161231.xml EX-101.INS 1536209
6 XBRL TAXONOMY EXTENSION SCHEMA rgrx-20161231.xsd EX-101.SCH 53586
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rgrx-20161231_cal.xml EX-101.CAL 31375
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rgrx-20161231_def.xml EX-101.DEF 279382
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE rgrx-20161231_lab.xml EX-101.LAB 343449
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rgrx-20161231_pre.xml EX-101.PRE 329815
Mailing Address 15245 SHADY GROVE ROAD SUITE 470 ROCKVILLE MD 20850
Business Address 15245 SHADY GROVE ROAD SUITE 470 ROCKVILLE MD 20850 301-208-9191
REGENERX BIOPHARMACEUTICALS INC (Filer) CIK: 0000707511 (see all company filings)

IRS No.: 521253406 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-15070 | Film No.: 17723127
SIC: 2834 Pharmaceutical Preparations